360 High-Risk Vulnerability Immunization Tool V2.0 vs DefenseArk Torus: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

DefenseArk Torus: Browser extension firewall blocking ads, phishing, and malware threats. built by DefenseArk (OpenAVN). Core capabilities include Lightweight browser extension that runs passively in the background, Blocks adware, phishing attempts, and malicious links, Prevents browser-delivered malware infections..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. DefenseArk Torus differentiates with Lightweight browser extension that runs passively in the background, Blocks adware, phishing attempts, and malicious links, Prevents browser-delivered malware infections.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). DefenseArk Torus is developed by DefenseArk (OpenAVN). Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and DefenseArk Torus serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Key differences: 360 High-Risk Vulnerability Immunization Tool V2.0 is Commercial while DefenseArk Torus is Free. Review the feature comparison above to determine which fits your requirements.